首页> 外文期刊>Clinical Biochemistry >Measurement of cystatin C in human urine by particle-enhanced turbidimetric immunoassay on an automated biochemistry analyzer
【24h】

Measurement of cystatin C in human urine by particle-enhanced turbidimetric immunoassay on an automated biochemistry analyzer

机译:全自动生物化学分析仪上的颗粒增强浊度免疫测定法测定人尿中的胱抑素C

获取原文
获取原文并翻译 | 示例
           

摘要

Background: Cystatin C (CysC), is produced by all the nucleated cells of the human body, is freely filtered by the kidney glomerulus and reabsorbed by the tubules. It is widely accepted that no tubular secretion of CysC occurs. Raised urinary levels are believed to indicate tubular damage. Methods: We report here the validation of a quantitative assay to measure urinary cystatin C (uCysC) using a commercial CysC kit based on a latex particle-enhanced turbidimetric immunoassay (PETIA), on an automated biochemistry analyzer. The clinical relevance of this assay was tested on several kidney disease patients and a reference range was determined using healthy controls. Results: The assay is precise (total CV. <. 4%), and sensitive (limit of quantification. =0.06. mg/dL, and limit of detection. =0.02. mg/L). Calibration is stable for at least 30. days. The assay showed very good linearity over the studied interval (0.02 to 2.25. mg/L). Recovery ranged from 101.62 to 106.49%. The analyte is stable, at 4. °C for at least 2. days, and at 20. °C for 48. h. The upper reference value was 0.12. mg/L Median uCysC concentration in 30 acute kidney injury patients (1.47. mg/L, interquartile range. =0.27-3.87. mg/L) and was significantly higher than that in 25 patients with normal kidney function (0.05, 0.03-0.12; p. <. 0.0001), 30 patients with chronic kidney disease (0.13, 0.05-0.77; p. <. 0.0001) and 15 patients with pre-renal azotemia (0.15, 0.08-0.31; p. <. 0.0001). Conclusion: Our data indicate that uCysC can be processed on automated biochemistry analyzers and its measurement could easily be added to a standard panel to screen kidney diseases.
机译:背景:胱抑素C(CysC)由人体的所有有核细胞产生,被肾小球自由过滤并被肾小管重吸收。众所周知,没有发生CysC的肾小管分泌。尿水平升高被认为表明肾小管损伤。方法:我们在这里报告了使用基于乳胶颗粒增强浊度免疫测定法(PETIA)的商业化CysC试剂盒,在自动化的生物化学分析仪上对定量尿液胱抑素C(uCysC)进行定量测定的验证。在几位肾脏疾病患者中测试了该测定法的临床相关性,并使用健康对照确定了参考范围。结果:该测定法精确(总CV。<。4%)和灵敏(定量极限= 0.06。mg / dL,检测极限= 0.02。mg / L)。校准至少稳定30天。该测定在研究的区间内(0.02至2.25。mg / L)显示出非常好的线性。回收率从101.62%到106.49%。分析物是稳定的,在4.°C下至少需要2天,在20°C下可以稳定48. h。最高参考值为0.12。 mg / L 30例急性肾损伤患者的uCysC浓度中位数(1.47。mg / L,四分位间距= 0.27-3.87。mg / L),显着高于25例肾功能正常的患者(0.05,0.03-0.12 ; p。<0.0001),30例慢性肾脏病患者(0.13,0.05-0.77; p。<0.0001)和15例肾前性氮质血症(0.15,0.08-0.31; p。<0.0001)。结论:我们的数据表明uCysC可以在自动生化分析仪上进行处理,其测量值可以轻松地添加到标准面板中以筛查肾脏疾病。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号